Opinion: The future of pandemic preparedness: agile coordination around clinical trials

The SARS-CoV-2 virus presented the world with a host of clinical challenges, not least its rapid transmission rate and ability to mutate into new, possibly even more contagious variants.

New vaccines, therapeutics, and diagnostics had to be tested under unusual and unpredictable circumstances; the most promising studies weren’t necessarily prioritized for high-quality clinical trials and competed for study participants; pandemic waves swept across the globe without real-time data; and feedback from health authorities varied significantly from one part of the world to the next.

Read the rest…